Abata Therapeutics

Abata Therapeutics was a biotechnology company developing engineered regulatory T cell (Treg) therapies aimed at restoring immune tolerance in tissue-specific autoimmune and inflammatory diseases, with lead programs directed at progressive multiple sclerosis and type 1 diabetes. Founded in 2021 and based in the Boston/Cambridge area (Watertown, Massachusetts), the company was launched by Third Rock Ventures and counted Lightspeed Venture Partners among its backers. As a therapeutics developer it operated no public developer program, API, or documentation surface. As of this enrichment pass its corporate domains (abatatx.com and abatatherapeutics.com) resolve to a WP Engine host but serve an unconfigured "Site Not Configured" 404, indicating the public website has been deprovisioned and the company appears to have wound down.

Abata Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Therapy, and Immunology.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyTherapeuticsCell TherapyImmunologyAutoimmuneLife SciencesHealthcare

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/abata-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: abata-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abata-therapeutics.png
name: Abata Therapeutics
description: Abata Therapeutics was a biotechnology company developing engineered regulatory T cell (Treg) therapies aimed
  at restoring immune tolerance in tissue-specific autoimmune and inflammatory diseases, with lead programs directed at progressive
  multiple sclerosis and type 1 diabetes. Founded in 2021 and based in the Boston/Cambridge area (Watertown, Massachusetts),
  the company was launched by Third Rock Ventures and counted Lightspeed Venture Partners among its backers. As a therapeutics
  developer it operated no public developer program, API, or documentation surface. As of this enrichment pass its corporate
  domains (abatatx.com and abatatherapeutics.com) resolve to a WP Engine host but serve an unconfigured "Site Not Configured"
  404, indicating the public website has been deprovisioned and the company appears to have wound down.
url: https://raw.githubusercontent.com/api-evangelist/abata-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
x-website-status: offline-404-wpengine-unconfigured
x-website-probed: '2026-07-17'
x-has-api-surface: false
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Therapeutics
- Cell Therapy
- Immunology
- Autoimmune
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence